LAUSR

HighlightsLow gene copy number of C4A is associated with increased susceptibility to SLE.Serositis is associated with low gene copy number of C4A in SLE patients.A basepair insertion (A) after A1112 causes a silencing mutation in C4A.A novel and accurate substrate binding assay for C4A and C4B was developed.The binding capacity of available C4 to its substrates is unaffected in SLE. ABSTRACT Genetic variation of the genes encoding complement component C4 is strongly associated with systemic lupus erythematosus (SLE), a chronic multi‐organ auto‐immune disease. This study examined C4 and its isotypes on a genetic, protein, and functional level in 140 SLE patients and 104 healthy controls. Gene copy number (GCN) variation, silencing CT‐insertion, and the retroviral HERV‐K(C4) insertion) were analyzed with multiplex ligation‐dependent probe amplification. Increased susceptibility to SLE was found for low GCN (⟨ 2) of C4A. Serositis was the only clinical manifestation associated with low C4A GCN. One additional novel silencing mutation in the C4A gene was found by Sanger sequencing. This mutation causes a premature stop codon in exon 11. Protein concentrations of C4 isoforms C4A and C4B were determined with ELISA and were significantly lower in SLE patients compared to healthy controls. To study C4 isotypes on a functional level, a new C4 assay was developed, which distinguishes C4A from C4B by its binding capacity to amino or hydroxyl groups, respectively. This assay showed high correlation with ELISA and detected crossing over of Rodgers and Chido antigens in 3.2% (8/244) of individuals. The binding capacity of available C4 to its substrates was unaffected in SLE. Our study provides, for the first time, a complete overview of C4 in SLE from genetic variation to binding capacity using a novel test. As this test detects crossing over of Rodgers and Chido antigens, it will allow for more accurate measurement of C4 in future studies.